Literature DB >> 4512319

Seizures associated with vincristine sulfate therapy.

F L Johnson, I D Bernstein, J R Hartmann, R L Chard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4512319     DOI： 10.1016/s0022-3476(73)80602-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 2.  Vincristine neurotoxicity. Pathophysiology and management.

Authors:  S S Legha
Journal:  Med Toxicol       Date:  1986 Nov-Dec

3.  Vincristine toxicity unrelated to dose.

Authors:  M J O'Callaghan; H Ekert
Journal:  Arch Dis Child       Date:  1976-04       Impact factor: 3.791

4.  Continuous vincristine infusion as part of a high dose chemoradiotherapy regimen: drug kinetics and toxicity.

Authors:  C R Pinkerton; B McDermott; T Philip; P Biron; C Ardiet; H Vandenberg; M Brunat-Mentigny
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Coma associated with vincristine therapy.

Authors:  J A Whittaker; D H Parry; C Bunch; D J Weatherall
Journal:  Br Med J       Date:  1973-11-10

6.  Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report.

Authors:  W Scheithauer; H Ludwig; E Maida
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

7.  Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment.

Authors:  L Vainionpää
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.